Institutional investors purchased a net $4.4 million shares of MNOV during the quarter ended September 2015. This may signal that the smart money is gaining interest in this company as the 19.21% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 3.5 Million shares of MediciNova Inc
SABBY CAPITAL LLC Bought 500.0 Thousand shares of MediciNova Inc
MILLENNIUM MANAGEMENT LLC Bought 229.1 Thousand shares of MediciNova Inc